Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

Aphria

Cowen

Cronos Group

Hain Celestial Group

Altria

Constellation Brands

One key metric is exploding. It’s not the right one.

This One Chart Shows Why You Should Avoid Canadian Cannabis Stocks Like the Plague

Even if you don't like Canopy Growth stock for its fundamentals, you should still give it a chance because of the underlying industry's upside potential.
The post Is Canopy Growth Stock Finally Priced Right for Bulls and Bears?

Is Canopy Growth Stock Finally Priced Right for Bulls and Bears?

Shares of cannabis stock Canopy Growth Corp (NYSE: CGC) traded higher by 3% on Wednesday but remain down 55% overall in the past year Canadian cannabis sales growth hasn’t lived up to expectations.

Large Option Trader Betting On Canopy Growth Bounce Ahead Of Earnings

CGC has the cash to wait for marijuana's full legalization, thanks to majority owner Constellation Brands.
The post Canopy Growth Stock Is the Best Card in a Bad Hand of Cannabis Stocks appeared first on InvestorPlace.

Canopy Growth Stock Is the Best Card in a Bad Hand of Cannabis Stocks

Curaleaf Holdings, Inc.

MedMen Enterprises Inc.

Could the cannabis industry actually help turn things around for the economy?

Why Legalizing Marijuana Could Give the U.S. Economy a Big Boost

Some investors have focused on Canopy's lawsuit with Go Farm Hemp. But there's a much bigger issue plaguing CGC stock at the moment.

Black Market Weed Hurts Struggling Canopy Growth Stock

On October 2, North America’s first publicly traded cannabis company completed an all-cash transaction to purchase the majority stake of Biosteel Sports Nutrition. The transaction gives Canopy Growth a 72% stake in the company with an agreed upon path to 100% ownership.

Canopy Growth And Biosteel To Introduce CBD Products To Sports Nutrition Market

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) issued an update Monday in its medical marijuana business in the United Kingdom and Luxembourg.

Canopy Growth Expands In UK, Luxembourg Medical Marijuana Markets

Will a new growth opportunity be able to turn the stock's fortunes around?

Is Canopy Growth’s Acquisition of Biosteel a Good Move for the Company?

One major cannabis grower just moved to seriously curb its production. Will other marijuana stocks soon follow?

Yikes! Will Canadian Pot Stocks Be Forced to Idle Their Grow Farms?

Canopy Growth Corporation (CGC) closed the most recent trading day at $20.35, moving +0.69% from the previous trading session.

Canopy Growth Corporation (CGC) Stock Moves 0.69%: What You Should Know

The cannabis giant is widening its European footprint.

Marijuana Stock Canopy Growth to Expand in the U.K., Luxembourg

Canadian cannabis company Canopy Growth Corp. CGC, -2.65% WEED, -2.71% said MOnday it has become the exclusive supplier of medical cannabis to Luxembourg in a deal that extends through Dec.

Canopy Growth to provide medical cannabis to Luxembourg and UK

CannTrust Holdings

Hint: It's not supply shortages or high tax rates.

The Single Biggest Issue With Marijuana Stocks Right Now

It's probably a smaller dollar figure than you would have expected.

Here's How Much Marijuana Canadians Bought in the First Year of Legalization

Medtronic

Quanterix

Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.

3 Medical Product Stocks - Likely to Beat This Earnings Season

Because of the guilt-by-association effect, Canopy Growth stock tumbled badly from the vaping crisis. However, the bad information proliferating over this epidemic may facilitate the contrarian argument.

This Bad News Could Be the Best Thing Ever for CGC Stock

What are investors worried about ahead of the upcoming CGC earnings report? For many, it's the expectation of near-term losses.

Where Is the Rebound for Fallen Canopy Growth Stock?

Taking the plunge in CGC today could prove a massive mistake, but that’s not to say buying Canopy Growth stock won’t make a worthy investment in the longer term.
The post Stay Far Away From Canopy Growth Stock … For Now appeared first on InvestorPlace.

Stay Far Away From Canopy Growth Stock … For Now

At the end of June, Canopy had net cash of $2.3 billion, 33% less than at the end of March. That’s the bad news.

7 Reasons to Buy Canopy Growth Stock

HEXO Corp

OrganiGram Holdings Inc.

Tilray Brands

The beaten-down pot industry is getting much-needed relief from Cannabis 2.0.

Here's Why Pot Stocks Are Surging Today

The fortunes of Canopy growth have turned sour in a very short period of time.  But this looks like an interesting opportunity for investors.

Load up on CGC Stock Before the Disappointment Starts to Fade

A potentially large new cannabis market is at hand in Canada. Here's what to look for.

3 Things You Should Expect With Canada's Cannabis 2.0 Recreational Marijuana Market

An Australian JV set up by Cronos is launching an IPO, while Canopy Growth is shedding its stake in a company there.

Marijuana Stocks Make These Moves In A New Cannabis Market

The company announced that it's closed its takeover of Beckley Canopy Therapeutics in the U.K. and jettisoned its AusCann stake in Australia.

News for Canopy Growth Stock (CGC)